DIA: Driving Insights to Action

A podcast featuring the activities of a TransCelerate BioPharma working group addressing Quality Management Systems (QMS) and their initial outline of a proposed conceptual framework for a clinical QMS. TIRS Editor-in-Chief Dr. Stephen Spielberg leads the conversation with Deb Driscoll from Merck, who leads the TransCelerate Quality Management Systems Initiative and Ann Meeker-O’Connell from Johnson &Johnson, who is the lead author on a paper “Enhancing Quality and Efficiency in Clinical Development Through a Clinical QMS Conceptual Framework: Concept Paper Vision and Outline” in the September, 2015 issue of TIRS.

Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders speaks with Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases. Dr. Wong-Rieger is the first DIA Board Member to represent the voice of the patient.